Stockscreener 앱 받기
29.61
0.24%
0.07
시간 외 거래:
29.40
-0.21
-0.71%
Tg Therapeutics Inc 주식(TGTX)의 최신 뉴스
State of New Jersey Common Pension Fund D Decreases Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
When (TGTX) Moves Investors should Listen - Stock Traders Daily
Entropy Technologies LP Purchases Shares of 31,200 TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
Principal Financial Group Inc. Raises Stock Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Acquired by Amalgamated Bank - MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Acquired by Los Angeles Capital Management LLC - MarketBeat
Insider Sale: Director Laurence Charney Sells 25,000 Shares of T - GuruFocus.com
Insider Sale: Director Sagar Lonial Sells 5,000 Shares of TG The - GuruFocus.com
New York State Teachers Retirement System Invests $1 Million in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
Don't Ignore The Insider Selling In TG Therapeutics - Simply Wall St
TG Therapeutics stock hits 52-week high at $28.43 - Investing.com India
TG Therapeutics stock hits 52-week high at $28.43 By Investing.com - Investing.com Canada
FY2024 EPS Estimates for TG Therapeutics Raised by Analyst - MarketBeat
TG Therapeutics (NASDAQ:TGTX) Sets New 1-Year HighWhat's Next? - MarketBeat
FY2027 EPS Forecast for TG Therapeutics Decreased by Analyst - MarketBeat
Optimistic Investors Push TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Up 27% But Growth Is Lacking - Simply Wall St
TG Therapeutics, Inc. Just Missed EarningsBut Analysts Have Updated Their Models - Yahoo Finance
FY2024 EPS Estimates for TG Therapeutics Lowered by Analyst - MarketBeat
HC Wainwright Boosts Earnings Estimates for TG Therapeutics - MarketBeat
TG Therapeutics Inc (TGTX) Q3 2024 Earnings: Revenue Hits $83.3M, EPS at $0.02, Surpassing Estimates - GuruFocus.com
HC Wainwright Increases TG Therapeutics (NASDAQ:TGTX) Price Target to $55.00 - MarketBeat
TG Therapeutics: Modest Q3 Sales Beat, Focus Shifts To Early 2025 Updates (NASDAQ:TGTX) - Seeking Alpha
TG Therapeutics (NASDAQ:TGTX) Price Target Raised to $22.00 at The Goldman Sachs Group - MarketBeat
TG Therapeutics (NASDAQ:TGTX) Announces Earnings Results - MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Q3 2024 Earnings Call Transcript - Insider Monkey
TG Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
TG Therapeutics Inc (TGTX) Q3 2024 Earnings Call Highlights: Rec - GuruFocus.com
TG Therapeutics Inc (TGTX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
TG Therapeutics Inc (TGTX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance
Earnings call: TG Therapeutics reports robust growth for BRIUMVI - Investing.com
TG Therapeutics: Q3 Earnings Snapshot - Darien Times
Earnings call: TG Therapeutics reports robust growth for BRIUMVI By Investing.com - Investing.com UK
TG Therapeutics Posts Strong Q3 Briumvi Revenue, Here’s Why Shares Fell - Seeking Alpha
TG Therapeutics (TGTX) Lags Q3 Earnings Estimates - MSN
(TGTX) Trading Advice - Stock Traders Daily
FUJIFILM Diosynth Biotechnologies To Manufacture TG Therapeutics' MS Drug - Contract Pharma
TG Therapeutics (NASDAQ:TGTX) Shares Gap DownHere's What Happened - MarketBeat
Morning Brew: Nvidia Joins Dow, Fed Rate Cut Looms, and TG Thera - GuruFocus.com
FUJIFILM Diosynth Biotechnologies Signs Manufacturing Supply Agreement with TG Therapeutics - The Manila Times
TG Therapeutics Reports Third Quarter 2024 Financial Results and Raises BRIUMVI® (ublituximab-xiiy) Full Year Revenue Guidance - The Manila Times
TG Therapeutics, Inc. (NASDAQ:TGTX) Stock Holdings Increased by Raymond James & Associates - Defense World
TG Therapeutics Reports Third Quarter 2024 Financial - GlobeNewswire
TG Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Bought by Raymond James & Associates - MarketBeat
State of Alaska Department of Revenue Acquires Shares of 76,130 TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
TG Therapeutics (TGTX) to Release Earnings on Monday - MarketBeat
TG Therapeutics stock hits 52-week high of $26.46 By Investing.com - Investing.com Canada
3.66%
1.11%
자본화:
|
볼륨(24시간):